PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 23, 2026eGastroenterology0 citationsOpen Access

Targeting gut immunity as a therapy for steatotic liver disease

View Full Paper
RGRachel Yue Gao

Key Points

  • The research aims to explore the role of gut immunity in treating steatotic liver diseases.
  • Review of relevant literature on gut immunity and liver disease
  • Analysis of mechanisms linking gut health to liver conditions
  • Gut immunity is highlighted as a potential therapeutic target in steatotic liver disease
  • Increased understanding of specific immune pathways may lead to novel treatments

Abstract

Liver disease represents a major global health challenge and encompasses a spectrum of disorders including steatotic liver diseases (such as alcohol-associated liver disease (ALD) and metabolic dysfunction-associated steatotic liver disease (MASLD)), viral hepatitis, fibrosis, cirrhosis and hepatocellular carcinoma.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Rachel Yue Gao (2026) studied this question.

synapsesocial.com/papers/69e9b8d485696592c86ebd12https://doi.org/10.1136/egastro-2026-100404
Ask AI
Helpful
Bookmark
Share
View Full Paper